The best discounts this week
Every week you can find the best discounts here.
Edel X
Velatox GF11
Sosum Soft
Sela Tox 10
S-DNA Inj.
Rejuran S
Rejuran S is a highly concentrated polynucleotide treatment designed to restore skin affected by scars and stretch marks. By injecting polynucleotides locally under the scar, Rejuran S revitalizes and restores damaged skin tissue. The product is FDA-approved and CE-certified, ensuring safety and compliance with regulatory standards. It offers faster tissue regeneration and wound healing compared to HA-only products, enhances skin elasticity, and delivers long-lasting aesthetic effects. Rejuran S is suitable for various application areas, including the face, forehead, neck, décolleté, and hands, and is particularly effective in addressing deep acne scars and promoting an even skin texture.
Main Ingredients:
- PN (Polynucleotide)
Packaging Units:
- 1ml x 1 syringe
- Delivered today (order Mon-Fri before 12:00, delivery between 17:00 and 22:00)
- Including shipping costs, sent by blonwe.com
- Pick up at a blonwe.com collection point is possible
- 30 days to change your mind and free returns
- Day and night customer service
Description
Rejuran S is a specialized skin booster formulated to effectively address atrophic, hypertrophic, and postoperative scars. This highly concentrated polynucleotide treatment restores skin afflicted by scars and stretch marks, promoting a smoother and more even texture.
Key Benefits:
- Scar Reduction: Significantly reduces the appearance of atrophic, hypertrophic, postoperative, and post-acne scars.
- Stretch Mark Treatment: Targets and improves the appearance of stretch marks.
- Enhanced Skin Elasticity: Supports the ligamentous apparatus and enhances skin firmness.
- Lip Augmentation: Addresses age-related changes in lip color, contours, and hydration.
- Neck, Décolleté, and Hand Rejuvenation: Provides comprehensive care for these areas.
Application Areas:
- Face
- Forehead
- Neck
- Décolleté
- Hands
Related products
Reviews
There are no reviews yet.